Please enable JavaScript to continue using this application.

Compare $CRDF vs $ICCC | Chartloom

Compare

$CRDF vs $ICCC

Cardiff Oncology Inc · ImmuCell Corp

CRDF

Cardiff Oncology Inc

ICCC

ImmuCell Corp

Compare $CRDF vs $ICCC

Comparing Cardiff Oncology Inc and ImmuCell Corp

CRDFCardiff Oncology Inc

ICCCImmuCell Corp

CRDFCardiff Oncology Inc

Market cap

$84M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

244.08x

Rev growth (TTM)

-7.0%

YTD performance

-59.4%

52W performance

-54.6%

FCF yield

-48.7%

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRDF

ICCC

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

ICCC

ImmuCell Corp

Market Cap

CRDF$84M

ICCC$89M

Enterprise Value

CRDF$75M

ICCC$88M

Price

CRDF$1.08

ICCC$9.80

P/E Ratio

CRDFN/A

ICCC114.37x

P/S Ratio

CRDF165.40x

ICCC2.89x

EV/Sales

CRDF147.30x

ICCC2.87x

EV/EBITDA

CRDF0.00x

ICCC14.10x

P/B Ratio

CRDF3.28x

ICCC2.82x

P/FCF Ratio

CRDFN/A

ICCC21.04x

EV/FCF

CRDF-1.83x

ICCC20.91x

PEG Ratio

CRDFN/A

ICCCN/A

Forward P/E (NTM)

CRDFN/A

ICCCN/A

Forward P/S (NTM)

CRDF244.08x

ICCCN/A

Revenue (TTM)

CRDF$508K

ICCC$31M

Revenue Growth (YoY)

CRDF-7.0%

ICCC8.5%

Forward Rev Growth

CRDF-19.6%

ICCC0.0%

Gross Margin (TTM)

CRDF100.0%

ICCC40.3%

Operating Margin (TTM)

CRDF0.0%

ICCC3.9%

EBITDA Margin (TTM)

CRDF-8251.0%

ICCC20.4%

Net Margin (TTM)

CRDF-7889.0%

ICCC2.6%

FCF Margin (TTM)

CRDF-8054.3%

ICCC13.7%

Net Income (TTM)

CRDF$-40M

ICCC$787K

FCF (TTM)

CRDF$-41M

ICCC$4M

EPS (TTM)

CRDF-$0.59

ICCC$0.09

ROE (TTM)

CRDF-10308.0%

ICCC2.7%

ROA (TTM)

CRDF-7551.0%

ICCC1.8%

ROIC (TTM)

CRDF-10308.0%

ICCC2.1%

Cash

CRDF$9M

ICCC$9M

Debt

CRDF$0

ICCC$8M

Net Cash/Debt

CRDF$9M

ICCC$557K

Current Ratio (TTM)

CRDF3.30x

ICCC4.75x

Quick Ratio (TTM)

CRDF3.21x

ICCC2.65x

Debt/Equity (TTM)

CRDF0.00x

ICCC0.26x

Debt/Assets (TTM)

CRDF0.0%

ICCC0.0%

Interest Coverage (TTM)

CRDFN/A

ICCCN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

ICCC0.00x

Beta

CRDF1.49

ICCC0.60

52W Performance

CRDF-54.6%

ICCC48.7%

YTD Performance

CRDF-59.4%

ICCC65.5%

% from 52W High

CRDF-67.4%

ICCC-19.0%

% from 52W Low

CRDF42.7%

ICCC116.8%

Asset Turnover (TTM)

CRDF0.01x

ICCC0.69x

FCF Yield (TTM)

CRDF-48.7%

ICCC4.8%

Earnings Yield (TTM)

CRDF-47.7%

ICCC0.9%

Dividend Yield (TTM)

CRDFN/A

ICCCN/A

Rule of 40

CRDF-8,061.3

ICCC22.2

EV/GP/RG

CRDFN/A

ICCCN/A

Ticker research

View CRDF research View ICCC research

Metric	CRDF Cardiff Oncology Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$84M	$89M
Enterprise Value	$75M	$88M
Price	$1.08	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	165.40x	2.89x
EV/Sales	147.30x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	3.28x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-1.83x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$31M
Revenue Growth (YoY)	-7.0%	8.5%
Forward Rev Growth	-19.6%	0.0%
Profitability
Gross Margin (TTM)	100.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-8251.0%	20.4%
Net Margin (TTM)	-7889.0%	2.6%
FCF Margin (TTM)	-8054.3%	13.7%
Net Income (TTM)	$-40M	$787K
FCF (TTM)	$-41M	$4M
EPS (TTM)	-$0.59	$0.09
ROE (TTM)	-10308.0%	2.7%
ROA (TTM)	-7551.0%	1.8%
ROIC (TTM)	-10308.0%	2.1%
Financial Health
Cash	$9M	$9M
Debt	$0	$8M
Net Cash/Debt	$9M	$557K
Current Ratio (TTM)	3.30x	4.75x
Quick Ratio (TTM)	3.21x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	0.60
52W Performance	-54.6%	48.7%
YTD Performance	-59.4%	65.5%
% from 52W High	-67.4%	-19.0%
% from 52W Low	42.7%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.69x
FCF Yield (TTM)	-48.7%	4.8%
Earnings Yield (TTM)	-47.7%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	22.2
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View ICCC research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

ICCC

2.89x

CRDF

165.40x

EV/FCF

CRDF

-1.83x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

CRDF

-7.0%

Forward Revenue Growth

ICCC

0.0%

CRDF

-19.6%

Profitability & performance

Gross Margin

CRDF

100.0%

ICCC

40.3%

ROE

ICCC

2.7%

CRDF

-10308.0%

FCF Yield %

ICCC

4.8%

CRDF

-48.7%

52-Week Performance

ICCC

48.7%

CRDF

-54.6%

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

ICCC

ImmuCell Corp

Market Cap

CRDF$84M

ICCC$89M

Enterprise Value

CRDF$75M

ICCC$88M

Price

CRDF$1.08

ICCC$9.80

P/E Ratio

CRDFN/A

ICCC114.37x

P/S Ratio

CRDF165.40x

ICCC2.89x

EV/Sales

CRDF147.30x

ICCC2.87x

EV/EBITDA

CRDF0.00x

ICCC14.10x

P/B Ratio

CRDF3.28x

ICCC2.82x

P/FCF Ratio

CRDFN/A

ICCC21.04x

EV/FCF

CRDF-1.83x

ICCC20.91x

PEG Ratio

CRDFN/A

ICCCN/A

Forward P/E (NTM)

CRDFN/A

ICCCN/A

Forward P/S (NTM)

CRDF244.08x

ICCCN/A

Revenue (TTM)

CRDF$508K

ICCC$31M

Revenue Growth (YoY)

CRDF-7.0%

ICCC8.5%

Forward Rev Growth

CRDF-19.6%

ICCC0.0%

Gross Margin (TTM)

CRDF100.0%

ICCC40.3%

Operating Margin (TTM)

CRDF0.0%

ICCC3.9%

EBITDA Margin (TTM)

CRDF-8251.0%

ICCC20.4%

Net Margin (TTM)

CRDF-7889.0%

ICCC2.6%

FCF Margin (TTM)

CRDF-8054.3%

ICCC13.7%

Net Income (TTM)

CRDF$-40M

ICCC$787K

FCF (TTM)

CRDF$-41M

ICCC$4M

EPS (TTM)

CRDF-$0.59

ICCC$0.09

ROE (TTM)

CRDF-10308.0%

ICCC2.7%

ROA (TTM)

CRDF-7551.0%

ICCC1.8%

ROIC (TTM)

CRDF-10308.0%

ICCC2.1%

Cash

CRDF$9M

ICCC$9M

Debt

CRDF$0

ICCC$8M

Net Cash/Debt

CRDF$9M

ICCC$557K

Current Ratio (TTM)

CRDF3.30x

ICCC4.75x

Quick Ratio (TTM)

CRDF3.21x

ICCC2.65x

Debt/Equity (TTM)

CRDF0.00x

ICCC0.26x

Debt/Assets (TTM)

CRDF0.0%

ICCC0.0%

Interest Coverage (TTM)

CRDFN/A

ICCCN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

ICCC0.00x

Beta

CRDF1.49

ICCC0.60

52W Performance

CRDF-54.6%

ICCC48.7%

YTD Performance

CRDF-59.4%

ICCC65.5%

% from 52W High

CRDF-67.4%

ICCC-19.0%

% from 52W Low

CRDF42.7%

ICCC116.8%

Asset Turnover (TTM)

CRDF0.01x

ICCC0.69x

FCF Yield (TTM)

CRDF-48.7%

ICCC4.8%

Earnings Yield (TTM)

CRDF-47.7%

ICCC0.9%

Dividend Yield (TTM)

CRDFN/A

ICCCN/A

Rule of 40

CRDF-8,061.3

ICCC22.2

EV/GP/RG

CRDFN/A

ICCCN/A

Ticker research

View CRDF research View ICCC research

Metric	CRDF Cardiff Oncology Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$84M	$89M
Enterprise Value	$75M	$88M
Price	$1.08	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	165.40x	2.89x
EV/Sales	147.30x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	3.28x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-1.83x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	N/A
Revenue & Growth
Revenue (TTM)	$508K	$31M
Revenue Growth (YoY)	-7.0%	8.5%
Forward Rev Growth	-19.6%	0.0%
Profitability
Gross Margin (TTM)	100.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-8251.0%	20.4%
Net Margin (TTM)	-7889.0%	2.6%
FCF Margin (TTM)	-8054.3%	13.7%
Net Income (TTM)	$-40M	$787K
FCF (TTM)	$-41M	$4M
EPS (TTM)	-$0.59	$0.09
ROE (TTM)	-10308.0%	2.7%
ROA (TTM)	-7551.0%	1.8%
ROIC (TTM)	-10308.0%	2.1%
Financial Health
Cash	$9M	$9M
Debt	$0	$8M
Net Cash/Debt	$9M	$557K
Current Ratio (TTM)	3.30x	4.75x
Quick Ratio (TTM)	3.21x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	0.60
52W Performance	-54.6%	48.7%
YTD Performance	-59.4%	65.5%
% from 52W High	-67.4%	-19.0%
% from 52W Low	42.7%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.69x
FCF Yield (TTM)	-48.7%	4.8%
Earnings Yield (TTM)	-47.7%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	22.2
EV/GP/RG	N/A	N/A
Ticker research	View CRDF research	View ICCC research